Izuma Networks is proud to announce its participation in the "Hyper-Distributed Computing Technology Development" project, ...

Company’s Recognition Based on Completeness of Vision and Ability to ExecuteBURLINGTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Progress ...

SeQure Dx specializes in assays that deliver precise editing confirmation and risk assessment for off-target effects, applicable across a wide range of viral and non-viral gene editing modalities.

Reports Q4 revenue $521M, consensus $518.54M. The company said, “Our solid sales growth in the second half of 2024 mirrors our plans for ...

2-Year U.S. Treasury Note Continuous Contract $102.805-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.531 0.141 0.13% 10-Year U.S. Treasury Note Continuous Contract $109.188 0.344 ...

Lynx Dx aims to address these challenges with the MPS2 test, which is designed to accurately assess the risk of clinically significant prostate cancer while reducing exposure to risks associated ...

2-Year U.S. Treasury Note Continuous Contract $102.766 0.008 0.01% 5-Year U.S. Treasury Note Continuous Contract $106.320-0.070-0.07% 10-Year U.S. Treasury Note Continuous Contract $108.766-0.188 ...

Feb. 03, 2025 /PRNewswire/ -- Lynx Dx, a leader in innovative diagnostic ... cancer using urine collected without a preceding digital rectal exam (DRE). This advancement further establishes ...

Montevideo, Minn.-based Integral dx, Inc. recently released a line of customizable Tier 4 switchers “in response to sold ...

Rockville’s MaxCyte has made its first acquisition in its more than quarter-century of operation. It’s keeping its eyes out ...

In a world driven by digital innovation, executives are encouraged to choose technology solutions capable of transforming their company’s output. Practically, however, this process can leave employees ...